View in EDS

Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture.

Saved in:
Bibliographic Details
Title: Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture.
Authors: Kajiwara, Ayami1, Saruwatari, Junji1, Sakata, Misaki1, Morita, Kazunori1, Kita, Ayana1, Oniki, Kentaro1, Yamamura, Masato2, Murase, Motoji2, Koda, Haruo2, Hirota, Seisuke2, Ishizuka, Tadao, Nakagawa, Kazuko kazukon@gpo.kumamoto-u.ac.jp
Source: Drug Safety. Oct2013, Vol. 36 Issue 10, p981-987. 7p.
Database: Environment Complete
Description
ISSN:01145916
DOI:10.1007/s40264-013-0077-z